🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
Medications to Treat Glaucoma | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Medications to Treat Glaucoma

NCLEX Review Guide: Glaucoma Medications

Overview of Glaucoma

Pathophysiology

  • Glaucoma is characterized by increased intraocular pressure (IOP) that damages the optic nerve, potentially leading to irreversible vision loss. The normal IOP ranges from 10-21 mmHg, with elevated pressures causing progressive damage to optic nerve fibers.
  • There are two main types: open-angle glaucoma (most common, gradual onset) and angle-closure glaucoma (acute, medical emergency).

Key Points

  • The goal of glaucoma treatment is to reduce intraocular pressure to prevent optic nerve damage.
  • Untreated glaucoma leads to permanent vision loss starting with peripheral vision.

Major Classes of Glaucoma Medications

Beta-Adrenergic Blockers

  • Mechanism of Action: Decrease aqueous humor production by blocking beta-adrenergic receptors in the ciliary body, reducing intraocular pressure by 20-30%.
  • Examples include timolol (Timoptic), betaxolol (Betoptic), and levobunolol (Betagan).

Key Points

  • First-line agents for most forms of glaucoma.
  • Contraindicated in patients with asthma, COPD, bradycardia, and heart block.
Beta-blockers can cause bradycardia, bronchospasm, and mask signs of hypoglycemia in diabetic patients. Always assess cardiac and respiratory status before administration.

Prostaglandin Analogs

  • Mechanism of Action: Increase uveoscleral outflow of aqueous humor, reducing IOP by 25-35%, making them the most effective single agents.
  • Examples include latanoprost (Xalatan), travoprost (Travatan), and bimatoprost (Lumigan).

Key Points

  • Often preferred first-line agents due to once-daily dosing and minimal systemic side effects.
  • Can cause permanent iris color change (brown pigmentation), eyelash growth, and periorbital fat atrophy.

Alpha-2 Adrenergic Agonists

  • Mechanism of Action: Decrease aqueous humor production and increase uveoscleral outflow, reducing IOP by 20-27%.
  • Examples include brimonidine (Alphagan) and apraclonidine (Iopidine).

Key Points

  • Brimonidine has neuroprotective properties that may help preserve visual function.
  • Contraindicated in patients taking MAO inhibitors and in infants due to CNS depression risk.
Alpha-2 agonists can cause drowsiness, fatigue, and dry mouth. Monitor patients for allergic conjunctivitis, which occurs in up to 20% of users.

Carbonic Anhydrase Inhibitors (CAIs)

  • Mechanism of Action: Decrease aqueous humor production by inhibiting carbonic anhydrase enzyme in the ciliary body, reducing IOP by 15-20%.
  • Topical examples include dorzolamide (Trusopt) and brinzolamide (Azopt). Oral forms include acetazolamide (Diamox).

Key Points

  • Oral CAIs are reserved for short-term or refractory cases due to significant systemic side effects.
  • Oral forms can cause paresthesias, fatigue, metallic taste, and kidney stones.

Cholinergic Agents (Miotics)

  • Mechanism of Action: Increase aqueous humor outflow by contracting the ciliary muscle and opening the trabecular meshwork, reducing IOP by 15-25%.
  • Examples include pilocarpine (Isopto Carpine) and carbachol (Isopto Carbachol).

Key Points

  • Less commonly used today due to side effects and availability of newer agents.
  • Pilocarpine is still used in acute angle-closure glaucoma emergencies.
Miotics cause pupillary constriction leading to reduced night vision and may induce myopia. These medications can cause headache and brow pain during initial treatment.

Combination Medications

  • Combination products enhance efficacy and improve adherence by reducing the number of drops needed daily.
  • Examples include dorzolamide/timolol (Cosopt), brimonidine/timolol (Combigan), and brinzolamide/brimonidine (Simbrinza).

Key Points

  • Combination therapy is indicated when monotherapy fails to adequately control IOP.
  • Patients should still be monitored for side effects from each component.

Commonly Confused Points

Medication Class Examples Primary Mechanism Key Side Effects Nursing Considerations
Beta Blockers Timolol, Betaxolol ↓ Aqueous production Bradycardia, Bronchospasm Contraindicated in asthma/COPD
Prostaglandin Analogs Latanoprost, Travoprost ↑ Uveoscleral outflow Iris color change, Eyelash growth Once daily dosing (evening)
Alpha-2 Agonists Brimonidine, Apraclonidine ↓ Aqueous production & ↑ Outflow Allergic reactions, Dry mouth Avoid in infants and with MAOIs
CAIs Dorzolamide, Acetazolamide ↓ Aqueous production Topical: Stinging; Oral: Paresthesias Oral forms cause electrolyte imbalances
Miotics Pilocarpine, Carbachol ↑ Trabecular outflow Miosis, Brow ache, Blurred vision Impairs night vision

Easily Confused Medications

  • Brimonidine vs. Bimatoprost: Brimonidine is an alpha-2 agonist that decreases aqueous production, while bimatoprost is a prostaglandin analog that increases outflow. Both names start with "B" but have completely different mechanisms and side effect profiles.
  • Timolol vs. Travoprost: Timolol is a beta-blocker with systemic contraindications in respiratory conditions, while travoprost is a prostaglandin analog with primarily local side effects. Both are common first-line agents but work through different mechanisms.

Administration Techniques

Proper Eye Drop Administration

  1. Wash hands thoroughly before administration.
  2. Tilt patient's head back slightly or have them lie down.
  3. Gently pull down lower eyelid to create a pocket.
  4. Hold dropper above eye (avoid touching eye or eyelid).
  5. Instill prescribed number of drops into the conjunctival sac.
  6. Apply gentle pressure to inner canthus for 1-2 minutes to prevent systemic absorption.
  7. Wait at least 5 minutes between different eye medications.

Key Points

  • Digital pressure at the inner canthus prevents drainage into nasolacrimal duct, reducing systemic absorption and side effects.
  • Multiple medications should be spaced 5-10 minutes apart to prevent washout effect.

Clinical Scenario

A 78-year-old patient with open-angle glaucoma is prescribed timolol 0.5% BID and latanoprost 0.005% QHS. The patient reports increasing shortness of breath and a heart rate of 58 BPM since starting these medications.

Assessment: The patient is experiencing beta-blocker side effects from timolol (bradycardia and bronchospasm).

Nursing Action: Hold the timolol, contact the prescriber immediately, and suggest an alternative medication such as a prostaglandin analog alone or combined with a CAI.

Study Tips

Memory Aids for Glaucoma Medications

Glaucoma Medication Suffixes

  • -olol = Beta blockers (timolol, betaxolol, levobunolol)
  • -prost = Prostaglandin analogs (latanoprost, travoprost)
  • -idine = Alpha-2 agonists (brimonidine, apraclonidine)
  • -zolamide = Carbonic anhydrase inhibitors (dorzolamide, brinzolamide)
  • -carpine = Cholinergic agents (pilocarpine)

Remember Side Effects: "ABCDE of Glaucoma Meds"

  • Allergic reactions (alpha-2 agonists)
  • Bradycardia (beta blockers)
  • Color changes in iris (prostaglandin analogs)
  • Diuresis and Dysgeusia (metallic taste with oral CAIs)
  • Eye pain and headache (miotics)

Mechanisms: "PACO" for Glaucoma Treatment Goals

  • Production decrease (beta blockers, alpha-2 agonists, CAIs)
  • Aqueous outflow increase (prostaglandins, miotics)
  • Combination therapy for resistant cases
  • Ophthalmic preservation (neuroprotection)

Common Pitfalls to Avoid

  • Timing confusion: Prostaglandin analogs are typically administered at night, while other agents are often given twice daily. NCLEX questions may test if you know the proper administration schedule.
  • Contraindication oversight: Beta blockers are commonly tested for their contraindications in respiratory conditions. Always check for asthma or COPD in case scenarios.
  • Systemic absorption: Questions may test knowledge of nasolacrimal occlusion technique to prevent systemic side effects.
A common NCLEX trap is presenting a patient with multiple comorbidities (e.g., glaucoma, asthma, and diabetes) and asking which glaucoma medication is most appropriate. Remember that beta blockers would be contraindicated in this scenario!

Patient Education

Key Teaching Points

  • Emphasize that glaucoma medications must be continued even when patients are asymptomatic, as vision loss is irreversible but can be prevented with consistent treatment.
  • Teach patients to report side effects but not to discontinue medications without consulting their healthcare provider, as abrupt discontinuation can cause IOP spikes.

Key Points

  • Instruct patients to maintain regular ophthalmology appointments for IOP monitoring and visual field testing.
  • Educate patients about proper administration technique to maximize effectiveness and minimize systemic absorption.

Self-Assessment

Quick Check

  1. Which class of glaucoma medications is most likely to cause bradycardia and bronchospasm?
  2. Which medication causes permanent iris color changes?
  3. When administering multiple eye drops, how long should a patient wait between medications?
  4. Which glaucoma medication is contraindicated in patients taking MAO inhibitors?
  5. What is the purpose of applying pressure to the inner canthus after administering eye drops?

Common Pitfalls

  • Don't confuse the mechanisms of different medication classes - beta blockers and CAIs decrease aqueous production, while prostaglandins and miotics increase outflow.
  • Remember that oral CAIs (acetazolamide) have significantly more systemic side effects than topical forms.
  • Be careful not to miss contraindications in clinical scenarios - the presence of asthma or COPD should immediately signal caution with beta blockers.

Remember that glaucoma medications are a common NCLEX topic due to their wide use and important contraindications. Mastering these medications will help you provide safe care to patients with visual disorders and ace your exam!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.